Around the world, millions of people are at an increased risk of illness or death from taking poor-quality medicines used to prevent or treat devastating illnesses. With funding from partners like the United States Agency for International Development (USAID), USP strengthens medicines quality assurance systems, increases the supply of quality-assured medicines, and develops capacity to detect and remove poor-quality medicines from the market. By sharing scientific expertise and providing technical support and leadership, we help local regulators improve and sustain local health systems, and enable manufacturers to supply quality-assured essential medicines for years to come. Through these efforts, we’re able to help prevent and treat diseases like HIV/AIDS, tuberculosis, malaria, and neglected tropical diseases, and improve maternal, newborn and child health.
Olakunle Ekundayo became a pharmacist to help others in need. And while his career ultimately took a different path, his role today as the CEO of a pharmaceutical manufacturing company has given him the opportunity to impact thousands of newborn lives in Nigeria, and beyond.
Around the world, millions of people are vulnerable to illness or death from poor-quality medicines. The risk is greatest in low- and middle-income countries.
People around the world should be able to trust that the medicines they use to treat their illnesses won’t make them sicker. USP’s Emily Kaine shares her perspectives about the threat of poor-quality medicines to global health.
- Advising Morocco’s National Control Laboratory to support its successful quality re-certification
- The Case for Quality: Incentive's Investments in Access to Quality Medicines (video)
- PQM 2018 Annual Performance Report
- Regulatory system strengthening for medicines (video)
- USP CDC AMR challenge commitment
- Scientific American highlights importance of medicine quality to fight antimicrobial resistance
- Poor-quality medicine: A global pandemic (A four-part series by Devex)